IRIDEX to Present at the 2020 Stifel Virtual Healthcare Conference
November 03 2020 - 4:05PM
IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans
to participate in the upcoming Stifel Virtual Healthcare
Conference.
David I. Bruce, IRIDEX’s President and Chief
Executive Officer, is scheduled to present on Tuesday, November 17,
2020, at 4:40 pm ET. Interested parties may access a live and
archived webcast of the presentation at http://www.iridex.com.
About IRIDEXIRIDEX Corporation is a worldwide
leader in developing, manufacturing, and marketing innovative and
versatile laser-based medical systems, delivery devices and
consumable instrumentation for the ophthalmology market. IRIDEX’s
proprietary MicroPulse® technology delivers a differentiated
treatment that provides safe, effective, and proven treatment for
targeted sight-threatening eye conditions. IRIDEX’s current product
line is used for the treatment of glaucoma and diabetic macular
edema (DME) and other retinal diseases. IRIDEX products are sold in
the United States through a direct sales force and internationally
primarily through a network of independent distributors into more
than 100 countries. For further information, visit the IRIDEX
website at www.iridex.com.
Investor Relations ContactLeigh Salvo(415)
937-5404investors@iridex.com
IRIDEX (NASDAQ:IRIX)
Historical Stock Chart
From Mar 2024 to Apr 2024
IRIDEX (NASDAQ:IRIX)
Historical Stock Chart
From Apr 2023 to Apr 2024
